Systemic and Intralesional Bevacizumab in Juvenile Onset Recurrent Respiratory Papillomatosis: A Report of Two Cases

Recurrent respiratory papillomatosis (RRP) is a stubborn disease. Despite volumes of researches done for a definite cause and management, the scientific community offers only theories for causation and options for treatments. Bevacizumab has emerged as a promising solution to the fear of sufferers o...

Descripción completa

Detalles Bibliográficos
Autores principales: Goyal, Arun, Kapoor, Dhruv, Saha, Richa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer India 2021
Materias:
Clinical Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8372222/
https://www.ncbi.nlm.nih.gov/pubmed/34426784
http://dx.doi.org/10.1007/s12070-021-02814-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8372222/
https://www.ncbi.nlm.nih.gov/pubmed/34426784
http://dx.doi.org/10.1007/s12070-021-02814-3

Ejemplares similares